Chemotherapy + immunotherapy, another positive step in mesothelioma treatment

NOW ENROLLING: Immunotherapy + chemotherapy as first line treatment for mesothelioma Drs. Anne Tsao of MD Anderson Cancer Center, Patrick Forde of Johns Hopkins, and James Stevenson of the Cleveland Clinic join Mary Hesdorffer to discuss a new clinical trial, Dream3r, a phase 3 study into the efficacy of combination chemotherapy with immunotherapy as first line treatment for mesothelioma.